an app for team leaders and time keepers
What about keeping all these times in a report? We can consult whenever we need to during the resuscitation and even afterwards for debriefings, analysis and clinical studies. iResuscitate provides this. iResuscitate is an app made for iPhone and Apple Watch; its purpose is to take all the times and make a functional report which can be utilised during and even after the cardiac arrest. I'm an emergency physician working in an emergency care unit, managing emergencies in and out the hospital. My passion for computer science brought me to develop this app which has been tested in the field and used in real situations.
This is an app for team leaders and time keepers, an app for those on the first line on resuscitation events, and an app for those working day and night in emergency. An app for physicians, paramedics, nurses and students. iResuscitate keeps times from the EMS arrival to the end of resuscitation, hospital ICU or cath lab admission, or ECMO starting point. You’ll be able to make a detailed report of all the times since the beginning of ACLS (Advanced Cardiac Life Support). All the aspects of cardiopulmonary resuscitation are taken into account: time management of all drugs and fluids with the suggested common dose, times of shocks with the possibility to choose the energy, insertion times of many devices from airway management to endovascular access including therapeutic hypothermia and automated CPR with a mechanical device. The exact time of the most common rhythms encountered, EtCO2 values and patients’ outcome are also considered. The latest version contains new fields for extracorporeal life support (ECLS), Trans Thoracic Echo (TTE) and Trans Esophageal Echo (TEE) in cardiac arrest. It means that iResuscitate supports the most advanced cardiopulmonary resuscitation: you can track times of artery and vein cannulation, circuit priming and pump start while the most common echographic signs (either trans-esophageal or trans-thoracic) are available on the time list. The most used drugs can be managed directly from the Apple Watch with rapid access to Epinephrine, Amiodarone and Shock delivered. You can start the session from your Apple Watch and end the session with the same device.
Another distinctive feature of this app is localisation: you can visualise all the sessions and then review, rescue and consult directly from a map on your iPhone. How important is it to share our knowledge about resuscitation, compare our best expertise with other colleagues in the same facility and also worldwide to find the best behavior, the most correct timings and create the best outcome for the patient? iResuscitate permits you to save all the reports on your iPhone and also forward them with the most common message apps and via email. The best feature on iResuscitate is at the end of the session you’ll be able to create a report that you can print and make part of the medical record or send by email and use to perform clinical studies on cardiac arrest. With iResuscitate you can share your studies with your colleagues making your local study a worldwide study.
Format: available for iPhone and AppleWatch
Offline use: yes
Audience level: emergency physicians, paramedics, nurses, students
Language: English, Italian, Spanish, Portuguese, French, Simplified Chinese.
Updates available: April 2018 with pre-arrival timings and new drugs
Cost: $1.99, €2.29
Published on : Tue, 6 Mar 2018
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The HAMILTON-C6 represents a new Generation of high-end ventilators. The combination of modularity, ease of use, mobility, and advanced features allows you to individualize your patient's ventilation therapy: - State-of-the-art ventilation modes for...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The fully-automated Accelerate Pheno™ system is designed to eliminate the lengthy culture and sample preparation steps required for most sample types prior to antimicrobial susceptibility testing. In addition, it hosts proprietary molecular identification...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery. All blood-contact surfaces of the NovaPort cannulas are coated with the bio-...